FLGT
Fulgent Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$21.69
−0.73%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$0.65
- Revenue estimate
- $86.3M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$0.58
- EPS estimate
- -$0.46
- Revenue actual
- $85.4M
- Revenue estimate
- $94.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +64.8%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | -$0.46 | -$0.58 | Miss -26.09% | $85.4M |
| May 1, 2026 | -$0.35 | -$0.36 | Miss -3.40% | $71.1M |
| Nov 7, 2025 | -$0.24 | $0.14 | Beat 158.33% | $84.1M |
| Aug 1, 2025 | -$0.23 | $0.07 | Beat 130.43% | $81.8M |
| May 2, 2025 | -$0.19 | $0.04 | Beat 121.05% | $73.5M |
| Feb 28, 2025 | -$0.31 | $0.04 | Beat 112.90% | $76.2M |
| Nov 8, 2024 | -$0.19 | $0.31 | Beat 263.16% | $71.7M |
| Aug 2, 2024 | -$0.31 | $0.15 | Beat 148.39% | $71.0M |
| May 3, 2024 | -$0.33 | -$0.01 | Beat 96.97% | $64.5M |
| Feb 28, 2024 | -$0.30 | $0.28 | Beat 193.33% | $70.5M |
| Nov 3, 2023 | -$0.33 | -$0.39 | Miss -18.18% | $84.7M |
| Aug 4, 2023 | -$0.33 | -$0.08 | Beat 75.76% | $67.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026